Package 62135-696-12

{"route": ["ORAL"], "spl_id": "459b81bd-0d79-ace2-e063-6294a90a3482", "openfda": {"upc": ["0362135696122"], "unii": ["MFM6K1XWDK", "91ZQW5JF1Z"], "rxcui": ["889614"], "spl_set_id": ["a0d735c2-e7a9-4843-a78d-203c9598682d"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 CAPSULE in 1 BOTTLE (62135-696-12)", "package_ndc": "62135-696-12", "marketing_start_date": "20220608"}], "brand_name": "CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE", "product_id": "62135-696_459b81bd-0d79-ace2-e063-6294a90a3482", "dosage_form": "CAPSULE", "pharm_class": ["Anticholinergic [EPC]", "Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cholinergic Antagonists [MoA]", "Decreased Parasympathetic Acetylcholine Activity [PE]", "Digestive/GI System Activity Alteration [PE]", "GI Motility Alteration [PE]"], "product_ndc": "62135-696", "dea_schedule": "CIV", "generic_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE", "active_ingredients": [{"name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "CLIDINIUM BROMIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA213530", "marketing_category": "ANDA", "marketing_start_date": "20201020", "listing_expiration_date": "20261231"}